If you’re checking your blood pressure at home, there’s a decent chance your doctor asked you to — home readings increasingly feed real treatment decisions: whether to start medication, adjust a dose, or rule out white-coat hypertension. That makes the accuracy of a $25 cuff a genuinely medical question. And unlike most home health gadgets, blood-pressure monitors have a public, independent, checkable answer: clinical validation.
(To be clear up front: this is consumer research about which devices appear on a validation registry, not medical advice. Questions about your readings or your treatment belong with your clinician.)
”FDA cleared” is not the claim you think it is
Nearly every home BP cuff sold in the US says “FDA cleared” somewhere on the box, and it’s true — blood-pressure cuffs are Class II medical devices, and clearance is required to sell one. But FDA clearance is a manufacturing and basic-safety review, typically granted because the device is substantially equivalent to one already on the market. It is not a demonstration that the device measures blood pressure accurately against a reference standard.
That demonstration is a separate, voluntary process: a formal clinical validation study run against an accepted protocol — today, the universal AAMI/ESH/ISO 81060-2:2018 standard — in which the device’s readings are compared against reference measurements on a defined patient population. Devices that pass get listed on public registries. The two that matter:
- STRIDE BP (stridebp.org), the international registry run by hypertension specialists, listing roughly 590 validated devices across about 200 brands.
- The US Blood Pressure Validated Device Listing (validatebp.org), AMA/AHA-affiliated. (Its site sat behind a bot wall when we did this research, so everything below is checked against STRIDE BP only.)
Most budget brands simply skip validation. Nothing forces them to do it, “FDA cleared” sounds reassuring enough on a listing page, and a validation study costs real money.
What we found when we checked 26 best-sellers
We took 26 widely sold home upper-arm monitors — the Amazon and Walmart chart regulars — and checked each one against STRIDE BP’s own manufacturer/model listing, pulled directly from the live registry on 2026-07-19. The full results, with per-row evidence notes, are in our validated blood-pressure monitors data table. The headline: 12 of 26 are confirmed on the registry.
The pattern is stark:
- The established medical brands clear the bar. Omron’s flagship models (Evolv, Platinum/BP5450), Withings’ entire BPM line, A&D Medical’s UA-651 and UA-767, Microlife’s home monitors, and Welch Allyn’s 1700 Series are all confirmed on STRIDE BP.
- Braun is a split verdict. Braun has five validated devices on the registry — but its popular US-market ExactFit line isn’t among them. That’s a specific-line gap, not a brand-wide one.
- The budget Amazon-chart brands are absent entirely. Paramed, LAZLE, Greater Goods, Wellue, iHealth, and Walmart’s house-brand ReliOn do not appear anywhere in STRIDE BP’s ~200-brand manufacturer list — not one SKU each. These are some of the most-purchased monitors in the country, and none of them shows up on the registry that tracks validated accuracy.
What “not found” does — and doesn’t — mean
Precision matters here, so here’s the honest framing: a “not validated” result in our table means the model was not found in STRIDE BP’s listing as of 2026-07-19 — not “proven inaccurate,” and not “proven absent from every registry anywhere” (we couldn’t query validatebp.org past its bot wall).
For brands with zero presence on the registry, absence is a strong signal: STRIDE BP lists only devices that passed an approved protocol, so a brand missing from its entire manufacturer list has, at minimum, no validated device the registry knows about.
For Omron specifically, there’s a real mapping caveat we’d rather surface than bury: STRIDE BP skews toward international submissions, and many of its Omron entries use EU/Japan model codes (HEM-xxxx) rather than US retail names. Our match for the US 10 Series, for example, goes through its international sibling, the M500 Intelli IT (HEM-7361T). The US-market Silver, Bronze, and Gold SKUs came up “not found” — but given the naming gap, we flag those as registry-code-uncertain rather than confirmed non-validations. Omron’s own literature cites accuracy studies for these lines; we just couldn’t confirm the specific SKUs on the registry under their US names. A couple of other rows (Beurer BM 27, HoMedics BPA-2100) carry a similar “brand present, SKU unconfirmed” flag.
How to use this when you buy
- Treat validation as the first filter, not a tiebreaker. If home readings will inform treatment, a registry-confirmed device is the conservative choice — and validated options start around $40 (A&D UA-651), so accuracy doesn’t require the $100+ tier.
- Check the registry yourself for the exact model. Registries update, and our pull is a snapshot dated 2026-07-19. STRIDE BP’s device search is public.
- Don’t read “FDA cleared” as an accuracy claim. Every device in our table carries it, including all the ones absent from the registry.
- Fit still matters. A validated monitor with the wrong cuff size reads wrong anyway — cuff-size ranges are a column in the data table for exactly that reason.
The full 26-row check — with each device’s cuff type, connectivity, cuff range, street price, and the specific registry evidence (or documented absence) behind every validated/not-found call — is in the Home Blood Pressure Monitors — Checked Against the Clinical Validation Registry table, including a filtered view of just the validated devices.